OPKO Biologics (formerly Prolor Biotech), a subsidiary of OPKO Health Inc., is a clinical-stage company developing next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs, utilizing CTP and reversible PEGylation technologies.
